Antiviral chemistry & chemotherapy

19.2k citations
938 papers · indexed · active since 1951
  • Virology top 2%
    • HIV Research and Treatment 356
    • HIV/AIDS drug development and treatment 459
    • HIV/AIDS Research and Interventions 76
  • Hepatology top 10%
    • Hepatitis C virus research 103
  • Epidemiology top 10%
    • Herpesvirus Infections and Treatments 184
    • Cytomegalovirus and herpesvirus research 174
    • Hepatitis B Virus Studies 78
    • Biochemical and Molecular Research 120

Antiviral chemistry & chemotherapy

929 papers receiving 18.4k citations

Peers

Antiviral chemistry & chemotherapy
Comparison fields: 5 of 168
  • Virology 4.4k
  • Infectious Diseases 7.7k
  • Hepatology 1.7k
  • Epidemiology 6.5k
  • Organic Chemistry 3.7k
Replace Advances in virus research with:
Advances in virus research United States
Current Opinion in Virology United States
Reviews in Medical Virology United States
Drug Resistance Updates United States
Infectious Disorders - Drug Targets Iran
Critical Reviews in Microbiology United States
Current HIV Research United States
Medicinal Research Reviews United States
Pharmacogenetics and Genomics United States
Critical Reviews in Biochemistry and Molecular Biology United States
Antiviral chemistry & chemotherapy relative to Advances in virus research United States Advances in virus research's profile →
Citations per field
00.5×9.1×
Advances in virus research · 1×
Citations per year

Countries where authors publish in Antiviral chemistry & chemotherapy

Since Specialization
Citations

This map shows the geographic impact of research published in Antiviral chemistry & chemotherapy. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Antiviral chemistry & chemotherapy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antiviral chemistry & chemotherapy more than expected).

Fields of papers published in Antiviral chemistry & chemotherapy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Antiviral chemistry & chemotherapy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Antiviral chemistry & chemotherapy.

About Antiviral chemistry & chemotherapy

The 938 papers published in Antiviral chemistry & chemotherapy in the last decades have received a total of 19.2k indexed citations . Papers published in Antiviral chemistry & chemotherapy usually cover Virology (374 papers), Infectious Diseases (533 papers) and Epidemiology (469 papers) specifically the topics of HIV/AIDS drug development and treatment (459 papers), HIV Research and Treatment (356 papers), Herpesvirus Infections and Treatments (184 papers), Cytomegalovirus and herpesvirus research (174 papers), Biochemical and Molecular Research (120 papers), Hepatitis C virus research (103 papers), Hepatitis B Virus Studies (78 papers) and HIV/AIDS Research and Interventions (76 papers). The most active scholars publishing in Antiviral chemistry & chemotherapy are Erik De Clercq, Donald F. Smee, Raymond F. Schinazi, R. Anthony Vere Hodge, Jan Balzarini, Suzanne M. Crowe, Katherine Kedzierska, Jan Balzarini, Robert W. Sidwell and Christopher McGuigan.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2026